Scorpio Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.62 Cr
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.30 Cr
- Revenue Growth %
- Profit Growth -291458.76%
- Ebitda -30.83%
- Net Worth -79.61%
- Total Assets -50.89%
About Scorpio Biotechnology
Scorpio Biotechnology Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2005 and has a history of 19 years and four months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.62 Cr.
The company currently has active open charges totaling ₹26.30 Cr.
Aman Agarwal and Madhu Agarwal serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24234UP2005PTC044055
-
Company No.
044055
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Scorpio Biotechnology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Agarwal
|
Director | 10-May-2024 | Current |
|
Madhu Agarwal
|
Additional Director | 07-Mar-2022 | Current |
Financial Performance of Scorpio Biotechnology.
Scorpio Biotechnology Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 291458.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scorpio Biotechnology?
In 2021, Scorpio Biotechnology had a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lalitamba Textiles Cluster Private LimitedAman Agarwal is a mutual person
-
Star Multi-Fab Private Limited
Aman Agarwal is a mutual person
-
Divya Trade Impex Private Limited
Aman Agarwal is a mutual person
-
Shri Varahi Enterprises Limited
Aman Agarwal and Madhu Agarwal are mutual person
-
Shrilakshmi Organics Limited
Aman Agarwal is a mutual person
-
Shrilakshmi Power Limited
Madhu Agarwal is a mutual person
Charges (Loans)
₹26.30 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 15.00 Cr
- Central Bank Of India : 11.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 May 2014 | Syndicate Bank | ₹15.00 Cr | Open |
| 11 Mar 2014 | Central Bank Of India | ₹11.30 Cr | Open |
How Many Employees Work at Scorpio Biotechnology?
Unlock and access historical data on people associated with Scorpio Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scorpio Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorpio Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
